Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: A long-term follow-up

Ophthalmology

Volumn 111, Issue 7, 2004, Pages 1380-1382

  Sami, Naveed ^a   Letko, Erik ^b   Androudi, Sofia ^b   Daoud, Yassine ^b   Foster, C Stephen ^b   Ahmed, A Razzaque ^a,b,c  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; BLINDNESS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONJUNCTIVITIS; CONTROLLED STUDY; DISEASE COURSE; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; MALE; MUCOUS MEMBRANE PEMPHIGOID; OCULAR CICATRICIAL PEMPHIGOID; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL ACUITY;

AGED; AUTOIMMUNE DISEASES; CONJUNCTIVITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 3042517026     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.11.012     Document Type: Article

References (8)

1. Chan L.S., Ahmed A.R., Anhalt G.J., et al. The first international consensus on mucous membrane pemphigoid. Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 138:2002;370-379
2. Fleming T.E., Korman N.J. Cicatricial pemphigoid. J Am Acad Dermatol. 43:2000;571-591
3. Foster C.S. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 84:1986;527-663
4. Foster C.S., Ahmed A.R. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid. A preliminary study. Ophthalmology. 106:1999;2136-2143
5. Ahmed A.R., Dahl M.V. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol. 139:2003;1051-1059
6. Ahmed A.R. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol. 45:2001;679-690
7. Ahmed A.R., Colon J.E. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid effects on disease progression in patients unresponsive to dapsone therapy. Arch Dermatol. 137:2001;1181-1189
8. Sami N., Bhol K.C., Ahmed A.R. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid. Clin Immunol. 102:2002;59-67